Reuters logo
BRIEF-Mallinckrodt to conduct Phase 4 trial of H.P. Acthar Gel
October 9, 2017 / 10:24 AM / 2 months ago

BRIEF-Mallinckrodt to conduct Phase 4 trial of H.P. Acthar Gel

Oct 9 (Reuters) - Mallinckrodt PLC

* Mallinckrodt will conduct Phase 4 trial of H.P. Acthar® Gel (repository corticotropin injection) for symptomatic sarcoidosis

* Mallinckrodt PLC - ‍enrollment of first subjects expected in early 2018 for Phase 4 trial of H.P. Acthar Gel​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below